neobookRx

Apnoea, Neonatal

Description Diagnostic criteria General and supportive measures Medicine treatment Referral ICD-10 code:  P28.3 DESCRIPTION A neonate presenting with episodes of cessation of breathing. Apnoea episodes in a previously asymptomatic well neonate may be the first indication of a serious underlying disease. Apnoea episodes in an already unwell neonate indicate deterioration in the condition of t

Description

Diagnostic criteria

General and supportive measures

Medicine treatment

Referral


ICD-10 code: P28.3

DESCRIPTION

A neonate presenting with episodes of cessation of breathing.

Apnoea episodes in a previously asymptomatic well neonate may be the first indication of a serious underlying disease.

Apnoea episodes in an already unwell neonate indicate deterioration in the condition of the neonate

DIAGNOSTIC CRITERIA

  • Cessation of respiration for longer than 20 seconds, with/without cyanosis, pallor or bradycardia.
  • Cessation of respiration for less than 20 seconds with cyanosis, pallor and/or bradycardia (heart rate < 100 bpm).

Central apnoea

Causes include:

  • IRDS,
  • prematurity,
  • hypoxia/hypercarbia,
  • sepsis,
  • acidosis,
  • meningitis,
  • temperature disturbances,
  • hypotension,
  • pneumonia,
  • intraventricular haemorrhage,
  • patent ductus arteriosus,
  • hypoglycaemia,
  • hypermagnesaemia,
  • atypical convulsions,
  • anaemia,
  • rough or excessive handling, and
  • medicines (sedatives, anticonvulsants, analgesics).

Obstructive apnoea

Neonates are obligatory ‘nose breathers’. Obstruction of the nares makes neonates prone to apnoea.

Causes of obstructive apnoea include:

  • choanal atresia,
  • gastro-oesophageal reflux,
  • micrognathia
  • macroglossia,
  • secretions (milk, meconium, blood, mucus) lodged in the upper airway, and
  • neck flexion or extension.

Reflex apnoea or vagally mediated apnoea

Is due to:

  • endotracheal intubation,
  • passage of a nasogastric tube,
  • gastro-oesophageal reflux,
  • overfeeding, and
  • suction of the pharynx or stomach.

Mixed apnoea

Apnoea caused by a combination of the above causes.

GENERAL AND SUPPORTIVE MEASURES

For all forms of neonatal apnoea:

  • Identify and treat the underlying cause.
  • Frequent gentle physical stimulation, e.g. rubbing of soles of feet.
  • Nurse preterm neonates in the prone position.
  • Maintain ambient temperature at the lower range of neutral thermal environment.
  • Maintain axillary temperature or anterior abdominal wall skin temperature at 36.2–36.8°C.
  • Maintain haematocrit at 30%.
  • Maintain nasal CPAP of 4–6 cmH2O. (Nasal CPAP – not for central apnoea except for apnoea of prematurity.)
  • Monitor vital signs and parameters relating to the underlying cause.

MEDICINE TREATMENT

To maintain oxygen/haemoglobin saturation of 90–95% or an oxygen tension in the blood at 60–80 mmHg:

  • Oxygen via nasal cannula or mask.

Only for apnoea of prematurity (not term infants):

  • Caffeine citrate, oral/IV:
    • Oral route strongly recommended (formulation can be extemporaneously compounded).
    • Loading dose: 20 mg/kg.
    • Maintenance dose: 5 mg/kg/24 hours. Start maintenance dose 24 hours after the loading dose. (Caffeine citrate 20 mg = caffeine base 10 mg.)

OR

(if caffeine not available) 

  • Aminophylline, IV/oral:
    • Loading dose: 8 mg/kg. (If IV infusion, administer over 30 minutes.)
    • Maintenance dose: 1.5–3 mg/kg/dose 8 hourly. Start maintenance dose 8 hours after loading dose.

Maintain aminophylline blood levels at 10–12 μg/mL.
If neonate responds favourably to caffeine/aminophylline, continue until neonate is apnoea free for 7 days.

REFERRAL

  • Recurrent life-threatening episodes of apnoea, not responding to adequate treatment and requiring ventilation.

Standard Treatment Guidelines And Essential Medicines List For South Africa, Hospital Level, Paediatrics, 2023 Edition

Chapter  19: Prematurity And Neonatal Conditions, 19.3 Prematurity/Preterm Neonate, 19.3.4 Apnoea, Neonatal

Drugs mentioned

ICD-10 codes

NeoHealth® ID 19901 · updated 5/11/2023